Saniona’s drug research is conducted primarily in three ways:



● Through its own drug discovery and development at an early stage.


Through cooperation with major pharmaceutical companies


Through Joint Ventures.


From the collaborations Saniona may receive payments in the form of research payments, milestone payments and royalties on marketed products.


Saniona has ongoing collaboration agreements with:





Boehringer Ingelheim GmbH


Cadent Therapeutics


● Productos Medix, S.A de S.V


 The Michael J. Fox Foundation for Parkinson’s Research


● The Treatment Research Center (TRC), University of Pennsylvania